Table 1.
Analyzed drug | Inhibition ± S.E.Ma (%) | ICb50 (mM) |
---|---|---|
Norfloxacin 0.005 mM | 77.3 ± 3.4 | 0.70 |
Norfloxacin 0.05 mM | 67.7 ± 2.1 | |
Norfloxacin 0.5 mM | 53.4 ± 2.3 | |
Norfloxacin 1.0 mM | 44.7 ± 3.6 | |
Moxifloxacin 0.005 mM | 76.6 ± 1.3 | 1.20 |
Moxifloxacin 0.05 mM | 70.9 ± 1.7 | |
Moxifloxacin 0.5 mM | 61.8 ± 3.1 | |
Moxifloxacin 1.0 mM | 56.1 ± 2.5 |
aSamples-contained phosphate buffer with different norfloxacin or moxifloxacin concentrations, mushroom tyrosinase (1,000 units), and L-DOPA solution (2 mg/ml). Tyrosinase activity was measured as described in “Materials and methods” section
b50 % inhibitory concentration